Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Simulations Plus Inc (NQ: SLP )

63.67 USD UNCHANGED
Streaming Delayed Price Updated: 5:05 PM EDT, Apr 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Simulations Plus Inc

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
A Peek Into The Markets: US Stock Futures Edge Higher; Inflation Data In Focus
Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade after the Dow Jones and Nasdaq dropped around 50 ... 
Tags SLP Eurozone SQ
From Benzinga
5 Stocks To Watch For April 13, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Fastenal Company (NASDAQ: FAST) to report ... 
Tags Market News Markets Small Cap
From Benzinga
Simulations Plus Inc (SLP) Q2 2021 Earnings Call Transcript
SLP earnings call for the period ending February 28, 2021. 
Tags SLP Market News
From Motley Fool
Simulations Plus: Q2 Earnings Insights
Shares of Simulations Plus (NASDAQ:SLP) moved higher after the company reported Q2 results. Quarterly Results Earnings per share ... 
Tags Earnings Benzinga Market News
From Benzinga
Simulations Plus Reports Record Second Quarter Fiscal 2021 Financial Results
Simulations Plus today reported record 2nd quarter results for FY2021. Net revenue of $13.1 million, up 27% over 2QFY20; YTD revenue of $23.8 million. 
From Business Wire News Releases
Earnings Scheduled For April 12, 2021
Companies Reporting Before The Bell • Aphria (NASDAQ:APHA) is projected to report earnings for its third ... 
Tags BHTG Earnings Scheduled CAN
From Benzinga
Simulations Plus's Earnings: A Preview
On Monday, April 12, Simulations Plus (NASDAQ:SLP) will release its latest earnings report. Benzinga's report can help you figure ... 
Tags BZI/EP SLP Market News
From Benzinga
Sum Up The Pieces: PSCH Could Be Worth $206
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Simulations Plus Reports Successful Results from AIDD Collaboration with Large Pharmaceutical Company
Simulations Plus reports excellent results from its Artificial Intelligence-driven Drug Design (AIDD) module in ADMET Predictor in testing by partner. 
From Business Wire News Releases
Simulations Plus Sets Date for Second Quarter Fiscal Year 2021 Earnings Release and Conference Call
Simulations Plus announced today that it will report its 2nd quarter fiscal year 2021 results on Monday, April 12, 2021, with a webcast at 4:15 pm ET. 
From Business Wire News Releases
Simulations Plus Forms Scientific Advisory Board for RENAsym Consortium
Simulations Plus announced the formation of a Scientific Advisory Board to guide the development of its RENAsym QST kidney injury software platform. 
From Business Wire News Releases
Simulations Plus Hosts the Inaugural 2021 MIDD+ Scientific Conference with over 50 Model-Informed Drug Development Sessions
Simulations Plus announced the successful launch of its 2021 MIDD+ Scientific Conference with speakers from industry, academia, & regulatory agencies. 
From Business Wire News Releases
Stocks With Rising Relative Strength: Simulations Plus
Simulations Plus shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Simulations Plus to Present at Oppenheimer Healthcare Conference
Simulations Plus CEO Shawn O'Connor will present at Oppenheimer's 31st Annual Healthcare Conference on March 16, 2021, beginning at 2:30 p.m. ET. 
From Business Wire News Releases
Stock Upgrades: Simulations Plus Shows Rising Relative Strength
A Relative Strength Rating upgrade for Simulations Plus shows improving technical performance. Will it continue? 
From Investor's Business Daily
Sum Up The Parts: PSCH Could Be Worth $202
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Simulations Plus Reaches 80-Plus Relative Strength Rating Benchmark
Simulations Plus shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82. 
From Investor's Business Daily
Simulations Plus and the University of Pittsburgh Drug Discovery Institute Receive SBIR Grant Funding for Large Molecule Safety Collaboration
Simulations Plus announced that its DILIsym division and the University of Pittsburgh Drug Discovery Institute jointly received a Phase I SBIR grant. 
From Business Wire News Releases
3 Top Healthcare Stocks That Can Make You Richer in 2021 (and Beyond)
What's better than rapid growth and a dividend payment? 
Tags Market News ABBV PINC
From Motley Fool
Simulations Plus to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Simulations Plus will host fireside chat at BTIG's Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Feb. 18, at 12pm ET. 
From Business Wire News Releases
Simulations Plus Releases GastroPlus® Version 9.8.1
Simulations Plus today announced the release of GastroPlus 9.8.1 with key enhancements to improve efficiency and inform regulatory decision making. 
From Business Wire News Releases
Stocks That Hit 52-Week Highs On Thursday
During Thursday's morning session, 255 companies made new 52-week highs. Facts of Interest: The largest ... 
Tags Intraday Update TRNS Markets
From Benzinga
Simulations Plus Enters Agreement with Distributor in China
Simulations Plus today announced an agreement to distribute Lixoft's MonolixSuite in China with Mosim, one of China's leading clinical CROs. 
From Business Wire News Releases
Stocks With Rising Relative Price Strength: Simulations Plus
Simulations Plus sees its Relative Strength Rating move into the 80-plus level. 
From Investor's Business Daily
Simulations Plus Expands Marketing and Sales Operations in South America Through Partnership with the Institute of Pharmaceutical Sciences
Simulations Plus today announced that it is partnering with the Institute of Pharmaceutical Sciences (ICF) in Brazil, to expand into South America. 
From Business Wire News Releases
NASDAQ:SLP Investor Alert: Investigation over Potential Wrongdoing at Simulations Plus, Inc.
San Diego, CA -- (SBWIRE) -- 01/25/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Simulations Plus, Inc. 
From SBWire - Latest Press Releases
Simulations Plus Awards Infrastructure Improvement Grant to Makerere University Department of Pharmacology and Therapeutics
Simulations Plus today announced that it has awarded a grant to Uganda's Makerere University funding upgraded infrastructure to facilitate research. 
From Business Wire News Releases
Simulations Plus Keeps Up Its Momentum in the New Fiscal Year
The company continues to anticipate swift, double-digit revenue growth over the next several quarters. 
Tags SLP Market News
From Motley Fool
70 Biggest Movers From Yesterday
Gainers CPS Technologies Corporation (NASDAQ: CPSH) shares climbed 113.8% to close at $6.84 on Tuesday. The company, last week, ... 
Tags Top Gainers BDTX PLUG
From Benzinga
Simulations Plus to Present at 23rd Annual Needham Virtual Growth Conference
Simulations Plus announced that CEO Shawn O'Connor will present at the 23rd Annual Needham Virtual Growth Conference on January 14, 2021, at 2pm ET. 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.